Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 9.30% vs 8.97% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 9.27% vs 26.33% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -3.99% vs 54.43% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 14.06% vs 29.87% in Mar 2025
Compare Profit and Loss Results of Indrapr.Medical
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
1,482.00
1,060.00
422.00
39.81%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
1,482.00
1,060.00
422.00
39.81%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
24.00
17.00
7.00
41.18%
Employee Cost
287.00
161.00
126.00
78.26%
Operating Expenses
335.00
300.00
35.00
11.67%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
105.00
5.00
100.00
2,000.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
7.00
5.00
2.00
40.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1,215.00
875.00
340.00
38.86%
Operating Profit (PBDIT) excl Other Income
266.00
185.00
81.00
43.78%
Other Income
28.00
29.00
-1.00
-3.45%
Operating Profit (PBDIT)
295.00
215.00
80.00
37.21%
Interest
6.00
26.00
-20.00
-76.92%
Profit before Depriciation and Tax
289.00
188.00
101.00
53.72%
Depreciation
43.00
46.00
-3.00
-6.52%
Profit Before Taxation & Exceptional Items
246.00
141.00
105.00
74.47%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
246.00
138.00
108.00
78.26%
Provision for Tax
62.00
35.00
27.00
77.14%
Profit After Tax
183.00
103.00
80.00
77.67%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
475.00
282.00
193.00
68.44%
Profit Available for appropriations
658.00
385.00
273.00
70.91%
Appropriations
658.00
385.00
273.00
70.91%
Equity Dividend (%)
40%
45%
-5.00
Earnings Per Share
20.03
6.55
13.48
205.80%
Profit And Loss - Net Sales
Net Sales 1,482.51 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 9.30% vs 8.97% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 266.92 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 9.27% vs 26.33% in Mar 2025
Profit And Loss - Interest
Interest 6.02 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -3.99% vs 54.43% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 183.62 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 14.06% vs 29.87% in Mar 2025
Footer loading
